2355262-97-2
2355262-97-2
Chemical Structure
Zuvotolimod
- CAS No.: 2355262-97-2
- Formula:C55H70N12O10
- Molecular Weight:1059.22
InChIKey: JMDJMYUCIGMITJ-UCNLINEOSA-N
SMILES: O=C(N1CC(C=C(NC(C2=CC3=C(C=C(C(N(CCC)CCC)=O)CC(N)=N3)C=C2)=O)C=N4)=C4CC1)OCC5=CC=C(NC([C@](NC([C@@](C(C)C)([H])NC(CCCCCN6C(C=CC6=O)=O)=O)=O)([H])CCCNC(N)=O)=O)C=C5
Biological Activity: Zuvotolimod is a myeloid cell agonist compound-linker for antibody conjugate. Zuvotolimod can be used in the research of cancer and hepatitis[1][2].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Zuvotolimod | 99.46% | Zuvotolimod is a myeloid cell agonist compound-linker for antibody conjugate. Zuvotolimod can be used in the research of cancer and hepatitis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Sabrina GENSSLER, et al. Anti-hgdf-15 antibody for use in the treatment of cancer in a patient in combination with a cancer antigen-targeted drug conjugate that induces cancer cell stress. WO2025146488A1. 2025-07-10.
-
[2]. Peter Armstrong Thompson, et al. Antibody construct-drug conjugate for the treatment of hepatitis. WO2019118884A1. 2019-06-20.
